NCT02303535

Brief Summary

The National Institute of Cardiovascular Outcomes Research (NICOR) collects data and produces analysis to enable hospitals and healthcare improvement bodies to monitor and improve the quality of care and outcomes of cardiovascular patients. The Congenital Heart Disease audit collects data on all cardiac surgery and therapeutic cardiac catheterisations procedures used to treat patients with congenital and acquired heart disease. For acquired heart disease, the audit covers all arrhythmias \& cardiomyopathies in patients less than 16 years old only. For congenital heart disease, the audit collects data on both children and adult patients. The audit covers all specialist centers in the UK and Republic of Ireland. The project aims to improve the quality of care for children and adults with congenital heart disease by providing national comparative analysis of procedure specific activity and outcomes of cardiac surgery and therapeutic cardiac catheterisation procedures. The audit also provides quality indicators for the antenatal detection of major congenital heart disease. The current dataset is available from here: http://www.ucl.ac.uk/nicor/audits/congenital/datasets

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2000

Longer than P75 for all trials

Geographic Reach
1 country

10 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2000

Completed
14.7 years until next milestone

First Submitted

Initial submission to the registry

November 25, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 1, 2014

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
Last Updated

November 4, 2016

Status Verified

October 1, 2016

Enrollment Period

16.9 years

First QC Date

November 25, 2014

Last Update Submit

November 3, 2016

Conditions

Keywords

Congenital heart diseaseEuropean Paediatric Cardiac Code Short ListSpecific Procedure DefinitionsOPCSpaediatricpediatric

Outcome Measures

Primary Outcomes (1)

  • 30 day survival rates

    The analysis shows the national survival rates at 30 days for each procedure and the national survival rates for individual procedures by age.

    30 day survival from operation date

Secondary Outcomes (1)

  • 1 year survival rates

    1 year survival rates after the date of the procedure

Study Arms (1)

Congenital

All patients with congential and acquired heart disease treated by cardiac surgery and therapeutic cardiac catheterisations procedures . For acquired heart disease, the audit covers all arrhythmias \& cardiomyopathies in patients less than 16 years old only. For congenital heart disease, the audit collects data on both children and adult patients.

Procedure: Cardiac SurgeryProcedure: Therapeutic cardiac catheterisations procedures

Interventions

All patients with congential and acquired heart disease treated by cardiac surgery procedures.

Also known as: Norwood procedure (Stage 1), Heart Transplant, TAPVD Repair + Arterial Shunt, Fontan procedure, Bidirectional cavopulmonary shunt, Senning or Mustard procedure, Truncus and interruption repair, Truncus arteriosus repair, Tricuspid valve replacement, Interrupted aortic arch repair, Multiple VSD Closure, Mitral valve replacement, Repair of total anomalous pulmonary venous drainage, Atrioventricular septal defect and tetralogy repair, Atrioventricular septal defect (complete) repair, Atrioventricular septal defect (partial) repair, Aortic valvotomy, Aortic valvoplasty, Anomalous coronary artery repair, Cor triatriatum repair, Arterial switch + VSD closure, Arterial switch (for isolated transposition), Pulmonary atresia VSD repair, Pulmonary valve replacement, Tetralogy with absent pulmonary valve repair, Tetralogy repair, Isolated coarctation repair, Aortic Valve Replacement - non Ross, Supravalvar aortic stenosis repair, Rastelli procedure, Aortic valve replacement - Ross, Aortic root replacement (not Ross), Subvalvar aortic stenosis repair, Aortopulmonary window repair, ASD repair, VSD Repair, Arterial shunt, Isolated Pulmonary artery band, PDA ligation (surgical)
Congenital

All patients with congential and acquired heart disease treated by therapeutic cardiac catheterisations procedures .

Also known as: Transcatheter PVR, VSD closure (catheter), Aortic balloon valvotomy, Coarctation angioplasty, Pulmonary artery stenting, ASD closure (catheter), PDA closure (catheter), Recoarctation angioplasty, Pulmonary balloon valvoplasty, Blade atrial septostomy, Coarctation stenting, PFO closure (catheter), Pulmonary valvotomy (radiofrequency), Duct Stenting, RVOT Stenting, Radiofrequency ablation for supraventricular tachycardia, Implantable Cardioverter Defibrillator
Congenital

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All potential patients are assessed through a systematic process of clinical evaluation, diagnostic assessment. Patient selection is effected in each individual unit through a multidisciplinary team process. These teams consist not only of cardiac surgeons and interventional cardiologists but also of many other medical specialties and allied professionals. The decision as to the access route to be used is determined by the multidisciplinary team.

You may qualify if:

  • Patient, judged by multidisciplinary team meeting as unsuitable for the procedure

You may not qualify if:

  • Patient, judged by multidisciplinary team meeting, as unsuitable for the procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (10)

Southampton General Hospital

Southampton, Hampshire, SO16 6YD, United Kingdom

RECRUITING

Royal Brompton Hospital

London, London, SW3 6NP, United Kingdom

RECRUITING

The Harley Street Clinic

London, London, W1G 8BJ, United Kingdom

RECRUITING

Alder Hey Hospital

Liverpool, Merseyside, L12 2AP, United Kingdom

RECRUITING

Royal Victoria Hospital Belfast

Belfast, Northern Ireland, BT12 6BA, United Kingdom

RECRUITING

John Radcliffe Hospital

Oxford, Oxfordshire, OX3 9DU, United Kingdom

RECRUITING

Freeman Hospital

Newcastle upon Tyne, Tyne and Wear, NE7 7DN, United Kingdom

RECRUITING

Leeds General Infirmary

Leeds, West Yorkshire, LS1 3EX, United Kingdom

RECRUITING

Queen Elizabeth Hospital (Edgbaston)

Birmingham, United Kingdom

RECRUITING

The Heart Hospital

London, United Kingdom

RECRUITING

Related Publications (1)

  • Pagel C, Utley M, Crowe S, Witter T, Anderson D, Samson R, McLean A, Banks V, Tsang V, Brown K. Real time monitoring of risk-adjusted paediatric cardiac surgery outcomes using variable life-adjusted display: implementation in three UK centres. Heart. 2013 Oct;99(19):1445-50. doi: 10.1136/heartjnl-2013-303671. Epub 2013 Apr 5.

    PMID: 23564473BACKGROUND

MeSH Terms

Conditions

Heart Defects, Congenital

Interventions

Cardiac Surgical ProceduresNorwood ProceduresHeart TransplantationFontan ProcedureArterial Switch OperationWound HealingSurgical Procedures, OperativeCathetersRadiofrequency AblationDefibrillators, Implantable

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Cardiovascular Surgical ProceduresThoracic Surgical ProceduresOrgan TransplantationTransplantationHeart Bypass, RightAnastomosis, SurgicalVascular GraftingVascular Surgical ProceduresRegenerationBiological PhenomenaEquipment and SuppliesRadiofrequency TherapyTherapeuticsAblation TechniquesDefibrillatorsElectrodesElectrical Equipment and SuppliesElectrodes, ImplantedProstheses and Implants

Study Officials

  • Rodney Franklin, MD

    Royal Brompton & Harefield NHS Foundation Trust

    STUDY CHAIR

Central Study Contacts

James CHAL, MHlthMgmnt

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 25, 2014

First Posted

December 1, 2014

Study Start

April 1, 2000

Primary Completion

March 1, 2017

Study Completion

March 1, 2017

Last Updated

November 4, 2016

Record last verified: 2016-10

Locations